Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474392 · ClinicalTrials.gov registry record
Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 340
- Enrollment target
NCT04474392: Completed study, sponsored by University of Colorado, Denver.
NCT04474392 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 340 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04474392 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 340 participants
- Enrollment target
Study Summary
The study is designed to learn more about the causes of rheumatoid arthritis (RA). People who get RA have elevated protein markers called autoantibodies in their blood years before initial symptoms of arthritis. The goal of this study is to learn more about how autoantibodies in RA might be related to inflammation in the lungs.
Primary Outcome
\*Sputum anti-CCP antibodies every year for 3 years (subjects At-Risk for RA); to identify whether sputum anti-CCP predicts incident RA
Interventions
- OTHER N/A (Observational Study)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2026-01-14 |
What the finished NCT04474392 record still lists
NCT04474392 is an observational study that tracks outcomes without assigning an intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which N/A (Observational Study) is the first listed.
NCT04474392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04474392 about?
NCT04474392 is a clinical study titled "Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins". The study is designed to learn more about the causes of rheumatoid arthritis (RA). People who get RA have elevated protein markers called autoantibodies in their blood years before initial symptoms of arthritis. The goal of this study is to learn more about how autoantibodies in RA might be related ...
What is the current status of trial NCT04474392?
This trial is currently completed. The enrollment target is 340 participants. The study started on 2020-08-01. Estimated completion is 2026-01-14.
What interventions are being tested in trial NCT04474392?
The interventions under investigation include: N/A (Observational Study) (OTHER).
Who is sponsoring clinical trial NCT04474392?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI